Article

Phase II trial of Pembrolizumab and Lenvatinib in Advanced Neuroendocrine Prostate Cancer (PLANE-PC)

2026-04-23

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> Effective therapies remain a currently unmet need for neuroendocrine prostate cancer (NEPC). Preclinical synergy in small cell cancer, and clinical tolerability led to the conduct of a multicenter phase II trial of lenvatinib and pembrolizumab combination. <bold>Patients and Methods:</bold> Eligible patients had histologically proven prostate cancer with ra...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a123c8e6-262b-5e5a-97bc-f7f53e39ac30
DOI: 10.21203/rs.3.rs-9471666/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Phase II trial of Pembrolizumab and Lenvatinib in Advanced Neuroendocrine Prostate Cancer (PLANE-PC)DOI 10.21203/rs.3.rs-9471666/v1Read

Neuroendocrine Prostate Cancer: Subtypes, Biology, and Clinical OutcomesSemantic proximity Read

Targeting Key Players of Neuroendocrine Differentiation in Prostate Cancer.Semantic proximity Read

Real-world experience in treatment outcome and genomic insights for metastatic prostate neuroendocrine carcinoma.Semantic proximity Read

Targeting Key Players of Neuroendocrine Differentiation in Prostate CancerSemantic proximity Read

[Neuroendocrine prostate cancer: Natural history, molecular features, therapeutic management and future directions].Semantic proximity Read

Role of MicroRNAs in Neuroendocrine Prostate CancerSemantic proximity Read

Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE).Semantic proximity Read

Treatment-induced neuroendocrine prostate cancer and de novo neuroendocrine prostate cancer: Identification, prognosis and survival, genetic and epigenetic factorsSemantic proximity Read

Treatment-related Neuroendocrine Prostate Carcinoma—Diagnostic and Molecular CorrelatesSemantic proximity Read

A Complete Response to Combined Immunotherapy in a Patient with an ATM plus SF3B1 Mutation and a Moderate Tumor Mutational Burden with a High-Grade Treatment-Emergent Neuroendocrine Prostate Cancer: Case Report and Review of the LiteratureSemantic proximity Read

Distinct prostate cancer neuroendocrine subtypes predict prognosis and guide personalized prostate-specific membrane antigen-targeted therapySemantic proximity Read

Clinicopathological and Genetic Analyses of Small Cell Neuroendocrine Carcinoma of the Prostate: Histological Features for Accurate Diagnosis and Toward Future Novel Therapies Short Running Title: Characteristics of Prostatic Small Cell Neuroendocrine CarcinomaSemantic proximity Read